
Bridge Pharmaceuticals Private Limited
Manufactures pharmaceutical formulations including oral suspensions, syrups, and liquids.
Manufactures pharmaceutical formulations including oral suspensions, syrups, and liquids.
Bridge Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 September 2003 and has a history of 21 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kistam Vijayalaxmi and Bomma Sowjanya serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U24239TG2003PTC041672
041672
Private Limited Indian Non-Government Company
11 Sep 2003
30 Nov 2021
31 Mar 2021
Unlisted
Roc Hyderabad
Bridge Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Cardiovascular Drugs & Medication, Kidney Drugs.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bomma Sowjanya ![]() | Managing Director | 19-Mar-2022 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kistam Vijayalaxmi ![]() | Director | 19-Mar-2022 | Current |
Bridge Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 55.91% increase. The company also saw a substantial improvement in profitability, with a 66.63% increase in profit. The company's net worth moved up by a moderate rise of 6.52%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Bridge Pharmaceuticals had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bridge Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bridge Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bridge Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kistam Vijayalaxmi was appointed as a Director was appointed as a Director on 19 Mar 2022 & has been associated with this company since 3 years 2 months .
Bomma Sowjanya was appointed as a Managing Director was appointed as a Managing Director on 19 Mar 2022 & has been associated with this company since 3 years 2 months .
Bridge Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Bridge Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
Bridge Pharmaceuticals Private Limited was registered on 11 Sep 2003 with Roc Hyderabad & aged 21 years 8 months as per MCA records.
Bridge Pharmaceuticals Private Limited was incorporated on 11 Sep 2003.
The authorized share capital of Bridge Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Bridge Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Bridge Pharmaceuticals Private Limited is Plot No.89 Prashanthi Nagar Ida Kukatpally, Hyderabad-072 India, Andhra Pradesh, Telangana, 500072.
The corporate identification number (CIN) of Bridge Pharmaceuticals Private Limited is U24239TG2003PTC041672 and the company number is 041672 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Bridge Pharmaceuticals Private Limited has risen by 55.91%.
The financial reports for the fiscal year 2020 indicates that The net worth of Bridge Pharmaceuticals Private Limited has experienced an upsurge of 6.52%.
The most recent Balance Sheet for Bridge Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2021.
Search company & director profiles for free and gain access to critical business data.
VD
RC
BS
BR
MR